Advisory Council for the Elimination of Tuberculosis (ACET), 15305-15306 [2016-06346]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 55 / Tuesday, March 22, 2016 / Notices
Contract Policy Division, at 202–969–
7226 or email kathlyn.hopkins@gsa.gov.
SUPPLEMENTARY INFORMATION:
asabaliauskas on DSK3SPTVN1PROD with NOTICES
A. Purpose
FAR Subparts 28.1 and 28.2; FAR
clauses at 52.228–1, 52.228–2, 52.228–
13, 52.228–15, 52.228–16; and
associated FAR standard forms
implement the statutory requirements of
the Miller Act (40 U.S.C. 3131 et seq.),
which requires performance and
payment bonds for any construction
contract exceeding $150,000, unless it is
impracticable to require bonds for work
performed in a foreign country, or it is
otherwise authorized by law. In
addition, the note to 40 U.S.C. 3132,
entitled ‘‘Alternatives to Payment Bonds
Provided by the Federal Acquisition
Regulation,’’ is implemented in the
FAR, which requires alternative
payment protection for construction
contracts that exceed $30,000 but do not
exceed $150,000.
Although not required by statute,
under certain circumstances the FAR
permits the Government to require
bonds on other than construction
contracts. In addition to the contract
clauses at FAR 52.228–1, 52.228–2,
52.228–13, 52.228–15, 52.228–16, this
information collection covers the
following FAR standard forms (SF) as
prescribed at FAR Subparts 28.1 and
28.2: SF 25, Performance Bond; SF 25A,
Payment Bond; SF 273, Reinsurance
Agreement for a Miller Act Performance
Bond; SF 274, Reinsurance Agreement
for a Bonds Statute Payment Bond; SF
24, Bid Bond; SF 25B, Continuation
Sheet (For Standard Forms 24, 25, and
25A); Standard Form 34, Annual Bid
Bond; Standard Form 275, Reinsurance
Agreement in Favor of the United
States; Standard Form 1416, Payment
Bond for Other Than Construction
Contracts; Standard Form 1418,
Performance Bond for Other Than
Construction Contracts; and Standard
Form 35, Annual Performance Bond.
The information collected under this
clearance provides the Government with
a form of security that the contractor
will not withdraw a bid or assures that
the contractor will perform its
obligations under a contract.
B. Annual Reporting Burden
Respondents: 974.
Responses per Respondent: 1.
Total Responses: 974.
Hours per Response: 1.
Total Burden Hours: 974.
C. Public comments
Public Comments are particularly
invited on: Whether this collection of
information is necessary for the proper
VerDate Sep<11>2014
19:56 Mar 21, 2016
Jkt 238001
performance of functions of the FAR,
and whether it will have practical
utility; whether our estimate of the
public burden of this collection of
information is accurate, and based on
valid assumptions and methodology;
ways to enhance the quality, utility, and
clarity of the information to be
collected; and ways in which we can
minimize the burden of the collection of
information on those who are to
respond, through the use of appropriate
technological collection techniques or
other forms of information technology.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the General Services Administration,
Regulatory Secretariat Division (MVCB),
1800 F Street NW., Washington, DC
20405, telephone 202–501–4755. Please
cite OMB Control No. 9000–0045, Bid
Guarantees, Performance, and Payment
Bonds, and Alternative Payment
Protections, in all correspondence.
Dated: March 17, 2016.
Lorin S. Curit,
Director, Federal Acquisition Policy Division,
Office of Governmentwide Acquisition Policy,
Office of Acquisition Policy, Office of
Governmentwide Policy.
15305
discussion, and evaluation of
applications received in response to
‘‘State Quitline Reimbursement for
Smoking Cessation Services Provided to
Current Smokers Eligible for Lung
Cancer Screening’’ SIP 16–004.
Contact Person for More Information:
Jaya Raman Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway,
Mailstop F80, Atlanta, Georgia 30341,
Telephone: (770) 488–6511, kva5@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control Prevention
and the Agency for Toxic Substances
and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–06353 Filed 3–21–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2016–06356 Filed 3–21–16; 8:45 am]
Centers for Disease Control and
Prevention
BILLING CODE 6820–EP–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Special Interest Project (SIP) 16–004,
State Quitline Reimbursement for
Smoking Cessation Services Provided to
Current Smokers Eligible for Lung
Cancer Screening.
Time and Date: 11:00 a.m.–6:00 p.m.,
EDT, April 26, 2016 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
Advisory Council for the Elimination of
Tuberculosis (ACET)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 10:00 a.m.–3:30 p.m.,
EDT, April 26, 2016.
Place: This meeting is accessible by
Web conference. Toll free number +1
877–951–7311, Participant Code:
6816256.
For Participants:
URL: https://www.mymeetings.com/nc/
join/
Conference number: PW7364589
Audience passcode: 6816256
Participants can join the event directly
at: https://www.mymeetings.com/nc/
join.php?i=PW7364589&p=6816
256&t=c.
Status: Open to the public, limited
only by the number of ports available
for the web conference. The meeting
accommodates 100 ports.
Purpose: This council advises and
makes recommendations to the
Secretary of Health and Human
Services, the Assistant Secretary for
Health, and the Director, CDC, regarding
the elimination of tuberculosis.
E:\FR\FM\22MRN1.SGM
22MRN1
15306
Federal Register / Vol. 81, No. 55 / Tuesday, March 22, 2016 / Notices
Specifically, the Council makes
recommendations regarding policies,
strategies, objectives, and priorities;
addresses the development and
application of new technologies; and
reviews the extent to which progress has
been made toward eliminating
tuberculosis.
Matters for Discussion: Agenda items
include the following topics: (1)
Discussion on U.S. Preventive Services
Task Force (USPSTF)
Recommendations; (2) Draft of TB
Treatment Guidelines; (3) Updates from
Workgroups; and (4) other tuberculosisrelated issues.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Margie Scott-Cseh, Centers for Disease
Control and Prevention, 1600 Clifton
Road, NE., M/S E–07, Atlanta, Georgia
30333, telephone (404) 639–8317;
Email: zkr7@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–06346 Filed 3–21–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2016–06345 Filed 3–21–16; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcements
(FOA) CK16–002, Spatially Scalable
Integrated Tick Vector/Rodent Reservoir
Management to Reduce Human Risk of
Exposure to Ixodes Scapularis Ticks
Infected with Lyme Disease Spirochetes
and CK16–003, Pre-travel Health
Preparation of International Travelers:
Expanding and Improving Data
Collection, Guidance, and Outreach.
Time and Date: 10:00 a.m.–5:00 p.m.,
April 14, 2016 (Closed).
VerDate Sep<11>2014
17:34 Mar 21, 2016
Jkt 238001
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Spatially Scalable Integrated Tick
Vector/Rodent Reservoir Management to
Reduce Human Risk of Exposure to
Ixodes Scapularis Ticks Infected with
Lyme Disease Spirochetes’’, CK16–002
and ‘‘Pre-travel Health Preparation of
International Travelers: Expanding and
Improving Data Collection, Guidance,
and Outreach’’, CK16–003.
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE., Mailstop E60, Atlanta,
Georgia 30333, Telephone: (404) 718–
8833.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Special Interest Project (SIP) 16–001,
Evaluating the Adoption and
Implementation of an Evidence-based
Patient Navigation Intervention for
Colonoscopy Screening, SIP 16–002,
Formative Development of an
Instrument to Predict Adherence to
Active Surveillance (AS) for Localized
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
Prostate Cancer, and SIP 16–003,
Implementation of Community-based,
Small Media Interventions to Promote
Colorectal Cancer Screening Among
Chinese Americans.
Time and Date: 11:00 a.m.–6:00 p.m.,
EDT, April 21, 2016 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Evaluating the Adoption and
Implementation of an Evidence-based
Patient Navigation Intervention for
Colonoscopy Screening’’, SIP 16–001,
‘‘Formative Development of an
Instrument to Predict Adherence to
Active Surveillance (AS) for Localized
Prostate Cancer’’, SIP 16–002 and,
‘‘Implementation of Community-based,
Small Media Interventions to Promote
Colorectal Cancer’’, SIP 16–003.
Contact Person for More Information:
Jaya Raman Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway,
Mailstop F80, Atlanta, Georgia 30341,
Telephone: (770) 488–6511, kva5@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–06354 Filed 3–21–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
E:\FR\FM\22MRN1.SGM
22MRN1
]]>Agencies
[Federal Register Volume 81, Number 55 (Tuesday, March 22, 2016)]
[Notices]
[Pages 15305-15306]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-06346]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Council for the Elimination of Tuberculosis (ACET)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Time and Date: 10:00 a.m.-3:30 p.m., EDT, April 26, 2016.
Place: This meeting is accessible by Web conference. Toll free
number +1 877-951-7311, Participant Code: 6816256.
For Participants:
URL: https://www.mymeetings.com/nc/join/
Conference number: PW7364589
Audience passcode: 6816256
Participants can join the event directly at: https://www.mymeetings.com/nc/join.php?i=PW7364589&p=6816256&t=c.
Status: Open to the public, limited only by the number of ports
available for the web conference. The meeting accommodates 100 ports.
Purpose: This council advises and makes recommendations to the
Secretary of Health and Human Services, the Assistant Secretary for
Health, and the Director, CDC, regarding the elimination of
tuberculosis.
[[Page 15306]]
Specifically, the Council makes recommendations regarding policies,
strategies, objectives, and priorities; addresses the development and
application of new technologies; and reviews the extent to which
progress has been made toward eliminating tuberculosis.
Matters for Discussion: Agenda items include the following topics:
(1) Discussion on U.S. Preventive Services Task Force (USPSTF)
Recommendations; (2) Draft of TB Treatment Guidelines; (3) Updates from
Workgroups; and (4) other tuberculosis-related issues.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Margie Scott-Cseh, Centers for
Disease Control and Prevention, 1600 Clifton Road, NE., M/S E-07,
Atlanta, Georgia 30333, telephone (404) 639-8317; Email: zkr7@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2016-06346 Filed 3-21-16; 8:45 am]
BILLING CODE 4163-18-P
